CN1246323C - 氮基喜树碱衍生物 - Google Patents

氮基喜树碱衍生物 Download PDF

Info

Publication number
CN1246323C
CN1246323C CNB028090543A CN02809054A CN1246323C CN 1246323 C CN1246323 C CN 1246323C CN B028090543 A CNB028090543 A CN B028090543A CN 02809054 A CN02809054 A CN 02809054A CN 1246323 C CN1246323 C CN 1246323C
Authority
CN
China
Prior art keywords
cpt
compound
amino
hydroxy
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB028090543A
Other languages
English (en)
Chinese (zh)
Other versions
CN1511159A (zh
Inventor
杨立锡
泮显道
王慧娟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Catholic Healthcare West
California Pacific Medical Center
Original Assignee
Catholic Healthcare West
California Pacific Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catholic Healthcare West, California Pacific Medical Center filed Critical Catholic Healthcare West
Publication of CN1511159A publication Critical patent/CN1511159A/zh
Application granted granted Critical
Publication of CN1246323C publication Critical patent/CN1246323C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CNB028090543A 2001-03-01 2002-02-06 氮基喜树碱衍生物 Expired - Fee Related CN1246323C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/797,765 2001-03-01
US09/797,765 US6403604B1 (en) 2001-03-01 2001-03-01 Nitrogen-based camptothecin derivatives

Publications (2)

Publication Number Publication Date
CN1511159A CN1511159A (zh) 2004-07-07
CN1246323C true CN1246323C (zh) 2006-03-22

Family

ID=25171748

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028090543A Expired - Fee Related CN1246323C (zh) 2001-03-01 2002-02-06 氮基喜树碱衍生物

Country Status (13)

Country Link
US (2) US6403604B1 (https=)
EP (1) EP1383772B1 (https=)
JP (1) JP4584538B2 (https=)
KR (1) KR100853141B1 (https=)
CN (1) CN1246323C (https=)
AT (1) ATE338047T1 (https=)
CA (1) CA2439787C (https=)
DE (1) DE60214359T2 (https=)
ES (1) ES2274020T3 (https=)
IL (2) IL157669A0 (https=)
MX (1) MXPA03007896A (https=)
NZ (1) NZ528115A (https=)
WO (1) WO2002070525A2 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12029736B2 (en) 2020-02-25 2024-07-09 Mediboston Limited Camptothecin derivatives and conjugates thereof
US12521444B2 (en) 2021-02-25 2026-01-13 Fortvita Biologics Limited Anti-HER2 antibody-drug conjugates and uses thereof

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150343A (en) * 1993-06-30 2000-11-21 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
US6492380B1 (en) * 1999-05-17 2002-12-10 Queen's University At Kingston Method of inhibiting neurotrophin-receptor binding
US6350756B1 (en) 2001-01-18 2002-02-26 California Pacific Medical Center Camptothecin derivatives
US6403604B1 (en) * 2001-03-01 2002-06-11 California Pacific Medical Center Nitrogen-based camptothecin derivatives
US6855720B2 (en) * 2001-03-01 2005-02-15 California Pacific Medical Center Nitrogen-based camptothecin derivatives
AU2003243397A1 (en) * 2002-06-03 2003-12-19 California Pacific Medical Center Homo-camptothecin derivatives
US6933302B2 (en) * 2002-06-03 2005-08-23 California Pacific Medical Center Nitrogen-based homo-camptothecin derivatives
FR2889528B1 (fr) * 2005-08-05 2007-09-07 Servier Lab Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2889527A1 (fr) * 2005-08-05 2007-02-09 Servier Lab Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
BRPI0615930A2 (pt) 2005-09-15 2016-08-23 Painceptor Pharma Corp métodos de modular a interação de uma neurotrofina e um receptor de neurotrofina, de tratar dor em um indivíduo, de tratar distúrbio inflamatório em um indivíduo, de tratar um distúrbio neurológico em um indivíduo, e de tratar uma doença ou distúrbio associado aos sistemas geniturinário e/ou gastrointestinal de um indivíduo, e, composto
US7875602B2 (en) * 2005-10-21 2011-01-25 Sutter West Bay Hospitals Camptothecin derivatives as chemoradiosensitizing agents
CN100586952C (zh) * 2006-11-10 2010-02-03 中国药科大学 噁唑骈喜树碱酯衍生物及其制备方法和用途
WO2009089537A2 (en) 2008-01-11 2009-07-16 Northwestern University Anti-cancer compounds
EP3415151A1 (en) * 2008-05-23 2018-12-19 The University of British Columbia Modified drugs for use in liposomal nanoparticles
WO2010148138A2 (en) * 2009-06-17 2010-12-23 Threshold Pharmaceuticals, Inc. Camptothecin derivatives
TWI549679B (zh) 2011-11-03 2016-09-21 台灣微脂體股份有限公司 疏水性喜樹鹼衍生物之醫藥組合物
US10980798B2 (en) 2011-11-03 2021-04-20 Taiwan Liposome Company, Ltd. Pharmaceutical compositions of hydrophobic camptothecin derivatives
CN109575044A (zh) * 2018-12-21 2019-04-05 西安交通大学 2-（喜树碱-10-氧基）乙酰胺类化合物和应用
HUE060364T2 (hu) * 2019-03-29 2023-02-28 Medimmune Ltd Vegyületek és konjugátumaik
PE20252282A1 (es) 2022-10-09 2025-09-18 Lanova Medicines Ltd Compuestos, composiciones y metodos
CN117285540B (zh) * 2023-09-27 2025-07-11 中国海洋大学 12-位取代的喜树碱衍生物及其用途

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943579A (en) 1987-10-06 1990-07-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble prodrugs of camptothecin
GB9320781D0 (en) 1993-10-08 1993-12-01 Erba Carlo Spa Polymer-bound camptothecin derivatives
US5965566A (en) 1993-10-20 1999-10-12 Enzon, Inc. High molecular weight polymer-based prodrugs
US5919455A (en) 1993-10-27 1999-07-06 Enzon, Inc. Non-antigenic branched polymer conjugates
US5646159A (en) * 1994-07-20 1997-07-08 Research Triangle Institute Water-soluble esters of camptothecin compounds
GB9504065D0 (en) 1995-03-01 1995-04-19 Pharmacia Spa Poly-pyrrolecarboxamidonaphthalenic acid derivatives
JPH08333370A (ja) * 1995-06-08 1996-12-17 Kyorin Pharmaceut Co Ltd 水に可溶な新規フルオロエチルカンプトテシン誘導体、及びその製造方法
US6339091B1 (en) 1995-06-21 2002-01-15 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Comptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues
AU7732996A (en) 1995-11-22 1997-06-11 Research Triangle Institute Camptothecin compounds with combined topoisomerase i inhibition and dna alkylation properties
US5731316A (en) 1996-01-30 1998-03-24 The Stehlin Foundation For Cancer Research Derivatives of camptothecin and methods of treating cancer using these derivatives
US6096336A (en) 1996-01-30 2000-08-01 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
IL127800A (en) 1996-08-19 2005-11-20 Bionumerik Pharmaceuticals Inc Highly lipophilic 7-substituted camptothecin derivatives and pharmaceutical compositions containing them
EP0961619A4 (en) 1996-09-27 2001-09-26 Bristol Myers Squibb Co HYDROLYSABLE DRUGS FOR THE RELEASE OF ANTI-CANCER DRUGS IN METASTATIC CELLS
ATE210673T1 (de) 1996-09-30 2001-12-15 Bayer Ag Glycokonjugate von modifizierten camptothecin- derivaten (20-o-verknüpfung)
TW464652B (en) 1996-10-30 2001-11-21 Tanabe Seiyaku Co S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
UA57757C2 (uk) 1996-12-20 2003-07-15 Сос'Єте Де Консей Де Решерш Е Даплікасьон С'Єнтіфік (С.К.Р.А.С.) Аналоги камптотецину, спосіб їх отримання (варіанти) і фармацевтична композиція
ID23424A (id) 1997-05-14 2000-04-20 Bayer Ag Glikokonjugat dari 20(s)-kamptotesin
GB9721070D0 (en) 1997-10-03 1997-12-03 Pharmacia & Upjohn Spa Bioactive derivatives of camptothecin
US6153655A (en) 1998-04-17 2000-11-28 Enzon, Inc. Terminally-branched polymeric linkers and polymeric conjugates containing the same
US6057303A (en) 1998-10-20 2000-05-02 Bionumerik Pharmaceuticals, Inc. Highly lipophilic Camptothecin derivatives
US6207832B1 (en) 1999-04-09 2001-03-27 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
WO2000066127A1 (en) 1999-05-04 2000-11-09 Bionumerik Pharmaceuticals, Inc. Novel highly lipophilic camptothecin analogs
US6765019B1 (en) 1999-05-06 2004-07-20 University Of Kentucky Research Foundation Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
US6288072B1 (en) * 1999-12-29 2001-09-11 Monroe E. Wall Camptothecin β-alanine esters with topoisomerase I inhibition
US6350756B1 (en) 2001-01-18 2002-02-26 California Pacific Medical Center Camptothecin derivatives
US6403604B1 (en) 2001-03-01 2002-06-11 California Pacific Medical Center Nitrogen-based camptothecin derivatives
GB0119578D0 (en) 2001-08-10 2001-10-03 Pharmacia & Upjohn Spa Fluoro linkers

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12029736B2 (en) 2020-02-25 2024-07-09 Mediboston Limited Camptothecin derivatives and conjugates thereof
US12521444B2 (en) 2021-02-25 2026-01-13 Fortvita Biologics Limited Anti-HER2 antibody-drug conjugates and uses thereof

Also Published As

Publication number Publication date
JP4584538B2 (ja) 2010-11-24
US6825207B2 (en) 2004-11-30
DE60214359T2 (de) 2007-08-30
ATE338047T1 (de) 2006-09-15
EP1383772B1 (en) 2006-08-30
US20030073698A1 (en) 2003-04-17
CN1511159A (zh) 2004-07-07
IL157669A (en) 2010-11-30
CA2439787C (en) 2011-05-24
CA2439787A1 (en) 2002-09-12
JP2004529114A (ja) 2004-09-24
EP1383772A2 (en) 2004-01-28
NZ528115A (en) 2006-04-28
WO2002070525A3 (en) 2003-02-20
KR100853141B1 (ko) 2008-08-20
MXPA03007896A (es) 2004-06-07
KR20040002872A (ko) 2004-01-07
US6403604B1 (en) 2002-06-11
IL157669A0 (en) 2004-03-28
DE60214359D1 (en) 2006-10-12
WO2002070525A2 (en) 2002-09-12
ES2274020T3 (es) 2007-05-16

Similar Documents

Publication Publication Date Title
CN1246323C (zh) 氮基喜树碱衍生物
CN1553802A (zh) 喜树碱衍生物
CN1255391C (zh) 作为血管破坏剂的colchinol衍生物
CN1027265C (zh) 水溶性喜树碱类似物的制备方法
CN88101588A (zh) 制备1，4-二取代的哌嗪类化合物的方法
CN1198827C (zh) 精选的K－252a衍生物
CN1741995A (zh) 异吲哚啉衍生物
CN1112363A (zh) 制备5，8-二氢萘醌衍生物的方法，新的5，8-二氢萘醌衍生物和它们作为抗癌药的用途
CN1867569A (zh) 作为抗癌剂的6－[(经取代的)苯基]三唑并嘧啶
CN1807413A (zh) 咔唑磺酰胺衍生物及其制备方法
CN1106405A (zh) 用于调节多药抗性的三取代嘧啶并[5，4-d]嘧啶类，及含有该化合物的药物组合物及其制备方法
CN1100425A (zh) 噻唑并嘧啶衍生物
CN1039026A (zh) 制备三环的3-氧代-丙腈衍生物的方法
CN1247589C (zh) 具有抗血管生成活性的吲哚的三环衍生物
CN1195757C (zh) 光学纯的喜树碱类似物及组合物和用途
CN100338066C (zh) 六环化合物
CN1256336C (zh) 新的4′－脱甲基－4′－o－取代的－1－脱氧鬼臼毒衍生物及其几何异构体,制备方法和包含它的抗癌组合物
CN1153763C (zh) 用于尿频/小便失禁的药物/预防剂和环庚三烯酮衍生物
CN1187352C (zh) 菲洛啉－7－酮衍生物以及它们的治疗用途
CN1289502C (zh) 苯并[a]吡喃并[3，2－h]吖啶－7－酮化合物、其制备方法及其药物组合物
CN1610681A (zh) 具有抗肿瘤活性的多环化合物
CN1156446C (zh) 茚并吲哚酮化合物、它们的制备方法和含有它们的药物组合物
CN1023320C (zh) 苯并嗪并利福霉素衍生物的制备方法
CN1195754C (zh) 菲咯啉－7－酮衍生物以及它们的治疗用途
CN1958589A (zh) 6－(芳氧甲基)－2－芳基－6,7－二氢－4H－吡唑并[5,1－c][1,4]噁嗪－4－酮衍生物及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060322

Termination date: 20130206